Andrew Huberman

Last updated

Andrew Huberman
Andrew D. Huberman, Ph.D..jpg
Huberman in 2016
Born
Andrew David Huberman

(1975-09-26) September 26, 1975 (age 48) [1]
Palo Alto, California, U.S.
Education University of California, Santa Barbara (BA)
University of California, Berkeley (MA)
University of California, Davis (PhD)
Scientific career
Fields Neuroscience
Institutions Stanford University
University of California, San Diego
Thesis Neural activity and axon guidance cue regulation of eye-specific retinogeniculate development  (2004)
Academic advisors Ben Barres (Stanford)
Barbara Chapman (UCD)
Website hubermanlab.com

Andrew David Huberman (born September 26, 1975) is an American neuroscientist and podcaster. He is an associate professor of neurobiology and ophthalmology at the Stanford University School of Medicine. Huberman has promoted and partnered with health supplement companies. [2]

Contents

Early life and education

Huberman was born in 1975 at Stanford Hospital in Palo Alto, California, to his father, an Argentine physicist and Stanford professor, and his mother, a children's book author. [3] [4] As a child, he was involved in athletics, including soccer and swimming. [3] He received his early education from Gunn High School. [5]

His parents divorced when he was 12 years old. [3] After his parents' divorce, he disengaged from traditional academics and had an interest in skateboarding. He also briefly considered a firefighting career. [3]

After a break from formal education and a reassessment of his interests influenced by therapy and an interest in biopsychology, Huberman resumed his studies and attended Foothill College. [3]

Huberman received a B.A. in psychology from the University of California, Santa Barbara, in 1998, and an M.A. in psychology from the University of California, Berkeley, in 2000. While at Berkeley, Huberman originally approached Carla J. Shatz to serve as his doctoral advisor; however, she declined the offer, concerned that he had a limited background in molecular and cellular biology and that she would be moving her lab to Harvard. She encouraged Huberman to transfer to the University of California, Davis, and reach out to Barbara Chapman. [6] Huberman obtained a Ph.D. in neuroscience from UC Davis in 2004. [3] [7]

Academic career

Huberman spent five years at Stanford University as a postdoc under Ben Barres between 2006 and 2011. [8] [9] From 2006 to 2009, he was a Helen Hay Whitney Postdoctoral Fellow. [9] During his postdoctoral work at Stanford, Huberman developed genetic tools to study the visual system and contributed to Thrasher . [3]

From 2011 to 2015, Huberman was an assistant professor of neurobiology and neuroscience at the University of California, San Diego. In 2016, Huberman took a faculty position at Stanford University. [3]

Huberman does research in his lab known as Huberman Lab, which he established at the University of California, San Diego, focusing on biological sciences. [3] Later, he transferred his lab to Stanford when he joined there in 2016. [3]

The lab gained attention in 2016 for using virtual reality (VR) to stimulate retinal neuron regrowth. [3] [10] [11] The lab also researched non-pharmacological interventions for anxiety disorders, including VR exposure to controlled stressors and breathing techniques. [3] [12]

In 2023, Huberman's lab, with David Spiegel, published a research paper on stress mitigation and carried out research on cortisol. [3] [7] The lab also released a study on the regeneration of the visual system, contributing to the understanding of stress management techniques and the potential for visual system recovery. [3]

Huberman has also led work investigating the regeneration of eye tissue in mice, which may have a future application in studying optical nerve regeneration in humans. [13] [14]

In 2024, New York Magazine stated that Huberman's lab at Stanford "barely exists", with only a single postdoc working there and the lab having been scaled back significantly during the COVID-19 pandemic. A spokesperson for Huberman said that the lab was still operational. [5]

Podcasts

Huberman was introduced to Robert Mohr in 2019, a New York–based health and fitness publicist who produced "The Fight with Teddy Atlas," a boxing podcast. As the COVID-19 pandemic progressed, Huberman grew dissatisfied with what he viewed as health authorities' narrow focus on the virus without providing guidance for improving public health. Mohr facilitated Huberman's appearances on major podcasts, including those hosted by Joe Rogan and Rich Roll. These appearances helped increase his social media following. By the end of 2020, Huberman had appeared on Lex Fridman's technology podcast. Fridman encouraged him to start his own podcast. [3]

In 2021 Huberman launched the Huberman Lab podcast. [7] In the same year, Huberman and Mohr co-founded Scicomm Media to produce science-related content. [3] As of 2023, the podcast had become the third most popular podcast in the US on Spotify platforms and the most followed show on Apple Podcasts. [15] [16] In 2023 GQ magazine called it "one of the most listened to shows in the world." [17] His YouTube channel has 5.5 million subscribers and his Instagram account has 6.4 million. [18] [19] [20]

According to immunologist, microbiologist, and science communicator Andrea Love, Huberman's podcast content is characteristic of pseudoscience, often presenting health claims as scientific when they are in reality insufficiently backed by scientific evidence, or simply wrong. [21] Jonathan Jarry from the Office for Science and Society has questioned Huberman's promotion of "poorly regulated" dietary supplements. According to Jarry, The Huberman Lab podcast has been sponsored by "companies offering questionable products from the perspective of science-based medicine". [2] Joseph Zundell, a cancer biologist, trusts Huberman's expertise in neuroscience but also criticized him for extrapolating animal research for human use without appropriate scientific justification and straying from his area of expertise. [18] These criticisms were echoed by New York Magazine, which also stated that Huberman often "posits certainty where there is ambiguity". [5] Neuroscientist David Berson, who has known Huberman since his postdoctoral research and has been a guest on his podcast, says that Huberman's research is respected among neuroscientists and described his podcast as "a fabulous service for the world" and a way to "open the doors" to the world of science. [18] However Berson also noted that the research community did not always approve of Huberman's monetization of his podcast through sponsors and partnerships. His promotion of unregulated health supplements has been particularly controversial, as these products often have little scientific evidence supporting their effectiveness. [18]

According to an article in Coda, Huberman has promoted anti-sunscreen views on his podcast, saying he is "as scared of sunscreen as I am of melanoma" and claiming that molecules in some types of sunscreen can be found in neurons 10 years after application without providing any evidence. [22] In a 2023 GQ article, Huberman said that he is not a "sunscreen truther" – a term used to describe anti-sunscreen conspiracy theorists. [23] Huberman has also expressed scepticism towards fluoridation and flu vaccination, despite scientific evidence for their effectiveness. [21]

Awards and recognition

For his dissertation, he received the Allan G. Marr Prize for Best Ph.D. Dissertation in 2005. [9]

Selected publications

Related Research Articles

Neuro-ophthalmology is an academically-oriented subspecialty that merges the fields of neurology and ophthalmology, often dealing with complex systemic diseases that have manifestations in the visual system. Neuro-ophthalmologists initially complete a residency in either neurology or ophthalmology, then do a fellowship in the complementary field. Since diagnostic studies can be normal in patients with significant neuro-ophthalmic disease, a detailed medical history and physical exam is essential, and neuro-ophthalmologists often spend a significant amount of time with their patients.

Thomas A. Reh is an American scientist and author.

<span class="mw-page-title-main">Ben Barres</span> American neurobiologist

Benjamin Arthur "Ben" Barres was an American neurobiologist at Stanford University. His research focused on the interaction between neurons and glial cells in the nervous system. Beginning in 2008, he was chair of the Neurobiology Department at Stanford University School of Medicine. He transitioned to male in 1997, and became the first openly transgender scientist in the National Academy of Sciences in 2013.

<span class="mw-page-title-main">David Eagleman</span> American neuroscientist, author, and science communicator (born 1971)

David Eagleman is an American neuroscientist, author, and science communicator. He teaches neuroscience at Stanford University and is CEO and co-founder of Neosensory, a company that develops devices for sensory substitution. He also directs the non-profit Center for Science and Law, which seeks to align the legal system with modern neuroscience and is Chief Science Officer and co-founder of BrainCheck, a digital cognitive health platform used in medical practices and health systems. He is known for his work on brain plasticity, time perception, synesthesia, and neurolaw.

Ignacio Provencio is an American neuroscientist and the discoverer of melanopsin, an opsin found in specialized photosensitive ganglion cells of the mammalian retina. Provencio served as the program committee chair of the Society for Research on Biological Rhythms from 2008 to 2010.

<span class="mw-page-title-main">Thomas Jessell</span>

Thomas Michael Jessell was the Claire Tow Professor of biochemistry and molecular biophysics at Columbia University in New York and a prominent developmental neuroscientist. In 2018, Columbia University announced his termination from his administrative positions after an internal investigation uncovered violations of university policies. He died shortly after from a rapidly neurodegenerative condition diagnosed as progressive supranuclear palsy.

David Spiegel is an American psychiatrist and the Wilson Professor and Associate Chair of Psychiatry at Stanford University School of Medicine, where he is known for his research into psycho-oncology; the neurobiology of therapeutic hypnosis, and the role of the mind-brain-body connection in cancer outcomes and management among other topics. He directs the Stanford Center on Stress and Health and is a recognized authority on hypnosis's clinical utility and neuroscience.

<span class="mw-page-title-main">Bernardo Huberman</span> American computer scientist

Bernardo Huberman is a fellow and vice president of the Next-Gen Systems Team at CableLabs. He is also a consulting professor in the Department of Applied Physics and the Symbolic System Program at Stanford University.

<span class="mw-page-title-main">King-Wai Yau</span> Chinese-American neuroscientist

King-Wai Yau is a Chinese-born American neuroscientist and Professor of Neuroscience at Johns Hopkins University School of Medicine in Baltimore, Maryland.

<span class="mw-page-title-main">Princeton Neuroscience Institute</span>

The Princeton Neuroscience Institute (PNI) is a center for neuroscience research at Princeton University. Founded in the spring of 2004, the PNI serves as a "stimulus for teaching and research in neuroscience and related fields" and "places particular emphasis on the close connection between theory, modeling, and experimentation using the most advanced technologies." It often partners with Princeton University's departments of Psychology and Molecular Biology.

John E. Dowling is an American neuroscientist and Gordon and Llura Gund Research Professor of Neurosciences at Harvard University. He is best known for his seminal work in vision science, having elucidated the biochemistry of rhodopsin and development of the vertebrate retina, as well as diseases that affect vision such as vitamin A deficiency and retinitis pigmentosa. He was elected to the American Academy of Arts and Sciences in 1972, the National Academy of Sciences in 1976, and the American Philosophical Society in 1992.

<span class="mw-page-title-main">Robert MacLaren</span> British ophthalmologist

Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator, or lead researcher, for the speciality of Ophthalmology. In addition, he is a member of the research committee of Euretina: the European Society of Retina specialists, Fellow of Merton College, in Oxford and a Fellow of the Higher Education Academy.

<span class="mw-page-title-main">Sergiu P. Pașca</span> Romanian-American scientist and physician at Stanford University

Sergiu P. Pașca is a Romanian-American scientist and physician at Stanford University in California. He is renowned for his groundbreaking work creating and developing stem cell-based models of the human brain to gain insights into neuropsychiatric disease. His lab was the first to develop and name assembloids: multi-unit self-organizing structures created in 3D cultures that allow for the study of human neural circuit and systems functions in vitro. Pașca’s lab generated and published human cortico-striatal and cortico-motor assembloids in 2020. Combining regionalized neural organoids pioneered in the lab and studies with human forebrain assembloids and transplantation, in 2024, Pașca developed a therapeutic for a severe genetic disorder called Timothy Syndrome, which was published on the cover of Nature.

Zhuo-Hua Pan is a Chinese-American neuroscientist, known for his foundational contributions to optogenetics. He is the Edward T. and Ellen K. Dryer Endowed Professor of Ophthalmology at Wayne State University, and Scientific Director of the Ligon Research Center of Vision at the university's Kresge Eye Institute.

Steven J. Fliesler is a distinguished American biochemist and researcher renowned for his contributions to the field of ophthalmology. He currently holds the title of SUNY Distinguished Professor and serves as the Meyer H. Riwchun Endowed Chair Professor of Ophthalmology at the University at Buffalo, The State University of New York (SUNY). Additionally, he also serves as the Vice-Chair for Research in the Department of Ophthalmology and acts as the Director of the Ira G. Ross Eye Institute Vision Research Center at the Buffalo VA Medical Center, VA Western NY Healthcare System (VAWNYHS), in Buffalo, NY.

<span class="mw-page-title-main">Paul A. Sieving</span>

Paul A. Sieving is a former director of the National Eye Institute, part of the U.S. National Institutes of Health. Prior to joining the NIH in 2001, he served on the faculty of the University of Michigan Medical School as the Paul R. Lichter Professor of Ophthalmic Genetics. He also was the founding director of the Center for Retinal and Macular Degeneration in the university's Department of Ophthalmology and Visual Sciences. 

Rachel Wong is an American neuroscientist who is a professor of Biological Structure at the University of Washington. She studies the developmental mechanisms that determine synaptic connectivity in the central nervous system. She was elected to the National Vision Research Institute of Australia in 2018 and the National Academy of Sciences in 2021.

Russell Van Gelder is an American clinician-scientist and board-certified ophthalmologist; he has served as the chair of the University of Washington Medicine Department of Ophthalmology since 2008 and Editor-in-Chief of the journal Ophthalmology since 2022. He is known for his research on the mechanisms of uveitis, non-visual photoreception in the eye, and vision-restoration methods for retinal degenerative disease, as well as his leadership and advisory positions in various American ophthalmological and medical societies.

<span class="mw-page-title-main">Jonathan Jarry</span> Canadian scientist

Jonathan Jarry is a Canadian scientist and science communicator working in Montreal, at McGill University's Office for Science and Society (OSS). He is frequently quoted by news media on topics such as misinformation.

Eduardo Jose Chichilnisky is an Argentine-born neurobiologist and academic. He has worked at Stanford University since 2013, and serves as John R. Adler Professor of Neurosurgery.

References

  1. ↑ "@hubermanlab" (Andrew D. Huberman, Ph.D.) on Twitter
  2. 1 2 Jarry J (7 April 2023). "Andrew Huberman Has Supplements on the Brain". McGill University Office for Science and Society. Retrieved 2023-06-15.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Béchard DE (July 2023). "The Huberman Effect". Stanford Magazine . Retrieved 2023-07-17.
  4. ↑ Lester Black (June 27, 2023). "How a Stanford professor became one of the world's top podcasters". SFgate.com . Retrieved June 27, 2023.
  5. 1 2 3 Howley K (2024-03-25). "Andrew Huberman's Mechanisms of Control". Intelligencer. Retrieved 2024-03-26.
  6. ↑ "HawkeTalk: The Power of Focus and Passion with Andrew Huberman". CSQ. October 2021.
  7. 1 2 3 Wiseman S (2023). "In conversation with Andrew Huberman". Nature Neuroscience. 26 (8): 1312–1315. doi:10.1038/s41593-023-01395-4. ISSN   1546-1726. PMID   37429915. S2CID   259657196.
  8. ↑ Barres B (2018). "Ben A. Barres" (PDF). In Albright T, R Squire L (eds.). The History of Neuroscience in Autobiography. Vol. 10. Society for Neuroscience. p. 62. ISBN   978-0-916110-10-9.
  9. 1 2 3 4 "Andrew D. Huberman | Stanford Medicine". CAP Profiles (in Samoan). Retrieved 2024-01-10.
  10. ↑ Lim JH, Stafford BK, Nguyen PL, Lien BV, Wang C, Zukor K, He Z, Huberman AD (August 12, 2016). "Neural activity promotes long-distance, target-specific regeneration of adult retinal axons". Nature Neuroscience. 19 (8): 1073–1084. doi:10.1038/nn.4340. PMC   5708130 . PMID   27399843.
  11. ↑ "Dr. Andrew Huberman on Virtual Reality Research". NIH News in Health. June 26, 2019.
  12. ↑ Robbins R (July 2, 2018). "A daredevil researcher's latest quest: to restore sight lost to glaucoma using virtual reality". STAT .
  13. ↑ Weintraub K (11 July 2016). "Regrown Brain Cells Give Blind Mice a New View". Scientific American.
  14. ↑ Barres 2018, p. 45.
  15. ↑ Shapiro A (2023-11-29). "Apple and Spotify have revealed their top podcasts of 2023. Here is what they do — and don't — tell us". The Verge. Retrieved 2023-12-12.
  16. ↑ "Apple shares the most popular podcasts of 2023". Apple Newsroom. Retrieved 2023-12-12.
  17. ↑ Gayomali C (2023-03-02). "The Real-Life Diet of Andrew Huberman, Who Switches to Red Party Lights After Dark". GQ . Retrieved 2024-03-29.
  18. 1 2 3 4 Ducharme J (2023-06-28). "How Andrew Huberman Got America to Care About Science". Time. Retrieved 2023-07-11.
  19. ↑ Spotify. "Podcast Charts". Podcast Charts. Retrieved 2022-12-19.
  20. ↑ "Apple Podcasts : United States of America : All Podcasts Podcast Charts - Top". chartable.com. Retrieved 2022-12-19.
  21. 1 2 Love A (27 March 2024). "So, Should You Trust Andrew Huberman?". Slate.
  22. ↑ Beres D (October 3, 2023). "The dangerous myths sold by the conspiritualists". Coda.
  23. ↑ Reiss S (2023). "What's Behind the Rise of the Sunscreen Truther?". GQ. Retrieved 2023-10-06.
  24. ↑ "The Association for Research in Vision and Ophthalmology- ARVO Awards Recipients: Chronological". www.arvo.org.
  25. ↑ "Awardees".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.